Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Willis Towers Watson Public Ltd (NQ: WTW )

315.18 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Willis Towers Watson Public Ltd

< Previous 1 2 3 4 Next >
Where Willis Towers Watson Stands With Analysts
Via Benzinga
Goldman Sachs Reveals Long-Term AI Portfolio: Here Are The 50 Stocks To Monitor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
What 7 Analyst Ratings Have To Say About Willis Towers Watson
Via Benzinga
The Latest Analyst Ratings for Willis Towers Watson
Via Benzinga
How Is The Market Feeling About Willis Towers Watson?
Via Benzinga
Future Challenges For Willis Towers Watson: Analyst Cautions On Downward EPS Revisions Amid Hiring Headwinds
BMO Capital Market analyst Michael Zaremski downgraded Willis Towers Watson PLC (NASDAQ: WTW) to Underperform from Market Perform at a decreased  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
Via Benzinga
Insurance Stocks Moving In Thursday's Intraday Session
Via Benzinga
10 Analysts Have This to Say About Willis Towers Watson
Via Benzinga
Will Chart Analysts Notice Bad Omen on Willis Towers Watson's Chart
Via Benzinga
10 Analysts Have This to Say About Willis Towers Watson
Via Benzinga
Willis Towers Watson Earnings Perspective: Return On Capital Employed
Via Benzinga
Where Willis Towers Watson Stands With Analysts
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
Via Benzinga
Patricia Guinn elected to Constellation Board
From Constellation Insurance, Inc.
Via GlobeNewswire
How Is The Market Feeling About Willis Towers Watson?
Via Benzinga
A Preview Of Willis Towers Watson's Earnings
Via Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control. 
Via Benzinga
BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 30 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
Via Benzinga
Microsoft To Rally Around 25%? Here Are 10 Other Analyst Forecasts For Tuesday
Credit Suisse cut the price target for Big Lots, Inc. (NYSE: BIG) from $13 to $7. Credit Suisse analyst Karen Short maintained an Underperform rating. Big Lots shares gained 2.9% to $8.15 in pre-market... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 20, 2023
Via Benzinga
Saia To Rally Around 33%? Here Are 10 Other Analyst Forecasts For Monday
Truist Securities cut the price target for Chevron Corporation (NYSE: CVX) from $193 to $190. Truist Securities analyst Neal Dingmann maintained a Hold rating. Chevron shares fell 1.2% to $166.54 in... 
Via Benzinga
Insurance Stocks Moving In Thursday's Intraday Session
Via Benzinga
Willis Towers Watson Gets Upgrade From Goldman Sachs As Analyst Sees Turnaround By 2HFY23
Goldman Sachs analyst Robert Cox upgraded Willis Towers Watson (NASDAQ: WTW) from Neutral to Buy  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 27, 2023
Via Benzinga
Earnings Scheduled For April 27, 2023
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter. 
Via Benzinga
Fox, MGM Resorts And 3 Other Stocks Insiders Are Selling
The Nasdaq closed lower on Friday, also recording losses for the week. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Earnings Scheduled For February 9, 2023
Companies Reporting Before The Bell • AstraZeneca (NASDAQ:AZN) is expected to report quarterly earnings at $0.67 per share on revenue of $11.21 billion. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 20, 2023
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.